Skip to main content
Erschienen in: International Journal of Mental Health and Addiction 3/2020

05.08.2019 | Original Article

Exploring Residential Models of Care for Treatment of Infectious Complications Among People Who Inject Drugs: a Systematic Review

verfasst von: Kaitlin G. Saxton, David Barrett, Laurie Gould, Rachel M. Sandieson, Sharon Koivu, Matthew J. Meyer

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

This article identifies, compares, and assesses residential models of care to treat infectious complications among people who inject drugs (PWID) through intravenous antibiotic (IV) therapy. Database searches in Ovid MEDLINE, Embase, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature Studies were performed. A Google web search was also performed. Studies published in English between 2000 and May 2017 that presented data on an out-of-hospital residential program for IV antibiotic treatment of infectious complications among PWID were included. Of the 2355 unique articles screened, 218 were reviewed in their entirety and three were included. Across the three included studies, no mortalities were reported during the study. Each study reported similar outcomes compared to in-hospital care. In the two studies reporting costs, residential care was substantially less expensive. This review indicates that residential treatment appears to be beneficial to PWID, hospitals, and the health care system.
Fußnoten
1
Naloxone is a safe and effective opioid reversal agent that has been used routinely in hospital and prehospital settings (Leece et al. 2013).
 
Literatur
Zurück zum Zitat Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., Flaxman, A., Murray, C. J. L., & Vos, T. (n.d.). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet, 382(9904), 1564–1574. https://doi.org/10.1016/S0140-6736(13)61530-5.CrossRef Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., Flaxman, A., Murray, C. J. L., & Vos, T. (n.d.). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet, 382(9904), 1564–1574. https://​doi.​org/​10.​1016/​S0140-6736(13)61530-5.CrossRef
Zurück zum Zitat Hsieh, Y.-H. (2008). HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr (1999), 49(4), 398–405.CrossRef Hsieh, Y.-H. (2008). HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr (1999), 49(4), 398–405.CrossRef
Zurück zum Zitat Jafari, S., Joe, R., Elliot, D., Nagji, A., Hayden, S., & Marsh, D. C. (2015). A community care model of intravenous antibiotic therapy for injection drug users with deep tissue infection for “reduce leaving against medical advice.”. Int J Ment Heal Addict, 13(1), 49–58. https://doi.org/10.1007/s11469-014-9511-4.CrossRef Jafari, S., Joe, R., Elliot, D., Nagji, A., Hayden, S., & Marsh, D. C. (2015). A community care model of intravenous antibiotic therapy for injection drug users with deep tissue infection for “reduce leaving against medical advice.”. Int J Ment Heal Addict, 13(1), 49–58. https://​doi.​org/​10.​1007/​s11469-014-9511-4.CrossRef
Zurück zum Zitat Lang, K., Neil, J., Wright, J., Dell, C. A., Berenbaum, S., & El-Aneed, A. (2013). Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy, 8, 35–35. https://doi.org/10.1186/1747-597X-8-35.CrossRef Lang, K., Neil, J., Wright, J., Dell, C. A., Berenbaum, S., & El-Aneed, A. (2013). Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy, 8, 35–35. https://​doi.​org/​10.​1186/​1747-597X-8-35.CrossRef
Zurück zum Zitat Leece, P. N., Hopkins, S., Marshall, C., Orkin, A., Gassanov, M. A., & Shahin, R. M. (2013). Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health, 104(3), e200–e204.CrossRef Leece, P. N., Hopkins, S., Marshall, C., Orkin, A., Gassanov, M. A., & Shahin, R. M. (2013). Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health, 104(3), e200–e204.CrossRef
Zurück zum Zitat Mallon, W. K. (2001). Is it acceptable to discharge a heroin user with an intravenous line to complete his antibiotic therapy for cellulitis athome under a nurse’s supervision? No: a home central line is too hazardous. West J Med, 174(3), 157–157.CrossRef Mallon, W. K. (2001). Is it acceptable to discharge a heroin user with an intravenous line to complete his antibiotic therapy for cellulitis athome under a nurse’s supervision? No: a home central line is too hazardous. West J Med, 174(3), 157–157.CrossRef
Zurück zum Zitat Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med, 151(4), 264–269 W64.CrossRef Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med, 151(4), 264–269 W64.CrossRef
Metadaten
Titel
Exploring Residential Models of Care for Treatment of Infectious Complications Among People Who Inject Drugs: a Systematic Review
verfasst von
Kaitlin G. Saxton
David Barrett
Laurie Gould
Rachel M. Sandieson
Sharon Koivu
Matthew J. Meyer
Publikationsdatum
05.08.2019
Verlag
Springer US
Erschienen in
International Journal of Mental Health and Addiction / Ausgabe 3/2020
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-019-00113-1

Weitere Artikel der Ausgabe 3/2020

International Journal of Mental Health and Addiction 3/2020 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.